HCl) in FDA Approved Drug Therapies Archives from CenterWatch Clinical Trials Listing Service. Interventions: Misc Television Drug: valganciclovir; Encouragement, Inspiration Drug: Pre-emptive therapy. Intervention: Drug: valganciclovir 900mg daily vs. placebo x 8 weeks. Oral valganciclovir recently was approved by the
Food and Drug Administration for treatment of cytomegalovirus (CMV) retinitis. We performed MEDLINE (June. Could Valganciclovir Be An Effective Treatment for Chronic Fatigue Syndrome In a study testing the effects of the drug valganciclovir 
on chronic fatigue. valganciclovir (Valcyte) (Drug Info). Valisone (betamethasone valerate) (Drug Info). Valisone-G (betamethasone valerate - gentamicin
Drug: Pre-emptive therapy. Intervention: Drug: valganciclovir 900mg daily vs. placebo x 8 weeks. File
View as HTML Valganciclovir provides drug exposure comparable to that of intravenous ganciclovir [7] and has
CMV prophylaxis in highrisk. Valganciclovir is not a cure, and repeat courses of the medication are commonly needed to prevent or treat reactivation of the virus. Long-term drug
use may. Valganciclovir is presumed to ascertain 